Deferiprone-d3

Deferiprone-d3

• CAS Number: 1346601-82-8
• UNSPSC Description: Deferiprone-d3 is the deuterium labeled Deferiprone. Deferiprone is the only orally active iron-chelating agent to be used therapeutically in conditions of transfusional iron overload[1][2].
• Target Antigen: Ferroptosis; HCV; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Apoptosis;Others
• Applications: Cancer-programmed cell death
• Field of Research: Cardiovascular Disease; Cancer
• Purity: 99.46
• Solubility: 10 mM in DMSO
• Smiles: OC1=C(C)N(C([2H])([2H])[2H])C=CC1=O
• Molecular Weight: 142.17
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Kontoghiorghes GJ, et al. Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine. Drug Saf. 2003;26(8):553-584.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported